CIBC Asset Management Inc Reduces Stake in HCA Healthcare, Inc. $HCA

CIBC Asset Management Inc cut its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 26,291 shares of the company’s stock after selling 1,197 shares during the period. CIBC Asset Management Inc’s holdings in HCA Healthcare were worth $11,205,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Hemington Wealth Management grew its position in shares of HCA Healthcare by 11.0% during the 3rd quarter. Hemington Wealth Management now owns 253 shares of the company’s stock valued at $107,000 after purchasing an additional 25 shares in the last quarter. Abound Wealth Management increased its stake in HCA Healthcare by 28.0% in the 3rd quarter. Abound Wealth Management now owns 119 shares of the company’s stock worth $51,000 after acquiring an additional 26 shares during the last quarter. ORG Partners LLC boosted its position in shares of HCA Healthcare by 27.9% during the 2nd quarter. ORG Partners LLC now owns 142 shares of the company’s stock valued at $55,000 after acquiring an additional 31 shares during the last quarter. Optas LLC increased its position in shares of HCA Healthcare by 4.5% in the third quarter. Optas LLC now owns 760 shares of the company’s stock worth $324,000 after purchasing an additional 33 shares during the last quarter. Finally, Sivia Capital Partners LLC grew its stake in HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after buying an additional 33 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts recently issued reports on HCA shares. Zacks Research lowered shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 27th. Weiss Ratings reissued a “buy (b)” rating on shares of HCA Healthcare in a report on Monday, December 29th. Stephens increased their price target on shares of HCA Healthcare from $450.00 to $500.00 and gave the company an “overweight” rating in a research report on Monday, October 27th. UBS Group upped their price objective on shares of HCA Healthcare from $495.00 to $525.00 and gave the company a “buy” rating in a research note on Monday, October 27th. Finally, Bank of America boosted their price target on shares of HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a research note on Monday, October 27th. Fourteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $488.75.

HCA Healthcare Trading Up 0.5%

Shares of NYSE:HCA opened at $473.08 on Tuesday. The company has a market cap of $107.95 billion, a price-to-earnings ratio of 18.29, a price-to-earnings-growth ratio of 1.30 and a beta of 1.36. HCA Healthcare, Inc. has a 12 month low of $295.00 and a 12 month high of $520.00. The company has a 50-day moving average price of $480.29 and a 200-day moving average price of $434.98.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. During the same quarter in the prior year, the company posted $4.90 EPS. HCA Healthcare’s quarterly revenue was up 9.6% compared to the same quarter last year. As a group, research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the transaction, the executive vice president directly owned 3,487 shares in the company, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.30% of the company’s stock.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.